MolNFT v1 · #60046 · protein

Crystal structure of the covalent adduct formed between tb B-lactamase and clavulanate

3CG5 · Beta-lactamase: “Crystal structure of the covalent adduct formed between tb B-lactamase and clavulanate”. X-ray diffraction, 2 ligands (ISS, PO4), 1 pocket (best druggability 0.38). MolNFT v1 #60046 on GenesisL1: 3D structure…

PDB: 3CG5
Type: protein
Length: 265 residues
Chains: 1
Method: x-ray diffraction
Collection: MolNFT v1 / PDB
Contract: 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner: 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule: Beta-lactamase
EC: 3.5.2.6
UniProt: P0C5C1
Ligands: ISS, PO4
Pockets: 1 · best druggability 0.38

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 17% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	Beta-lactamase (EC 3.5.2.6)	protein	265	46% helix, 17% strand	P0C5C1

Ligands and binding sites

ISS · (2E)-3-[(4-hydroxy-2-oxobutyl)amino]prop-2-enal · ligand · chains A
PO4 · Phosphate ion · ion · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	102	0.38	0.76	19	PO4, ISS

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

3CG5 · Crystal Structure of the Covalent Adduct Formed between TB B-lactamase and Clavulanate · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt P0C5C1
Elsewhere: RCSB PDB 3CG5 · PDBe 3CG5 · UniProt P0C5C1

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.